| Members |
targetComponentId |
| Congenital medial deviation |
Medial displacement |
| Congenital megaloureter (disorder) |
Dilatation of ureter |
| Congenital misalignment |
Misalignment (morphologic abnormality) |
| Congenital myelin deficiency of the optic disc |
Congenital anomaly of optic disc |
| Congenital myotonia |
myotonie congénitale, forme autosomique dominante |
| Congenital postural lordosis |
Congenital lordosis deformity of spine (disorder) |
| Congenital stenosis of pulmonary artery (disorder) |
Pulmonary artery stenosis |
| Congenital stricture of anus (disorder) |
Stricture of anus |
| Congenital tracheocele |
Congenital tracheocele |
| Congenital varix |
Congenital phlebectasia |
| Congestive heart failure clinical management plan (qualifier value) |
Congestive heart failure clinical management plan (record artifact) |
| Congo hemorrhagic fever (disorder) |
Crimean-Congo haemorrhagic fever |
| Conjoined twins causing disproportion |
Disproportion between fetus and pelvis due to conjoined twins (disorder) |
| Conjoined twins causing disproportion (disorder) |
Disproportion between fetus and pelvis due to conjoined twins (disorder) |
| Conjunctivoplasty with reconstruction of cul-de-sac and conjunctival graft (procedure) |
Reconstruction of conjunctival cul-de-sac with graft |
| Connection between lacrimal gland and nose NOS |
création d'une anastomose entre le système de drainage lacrymal et le nez |
| Connection of stomach to duodenum NEC |
Anastomosis of stomach |
| Connection of stomach to duodenum NOS |
Anastomosis of stomach |
| Connective tissue by site |
Connective tissue structure |
| Connective tissue disorder by body site |
affection du tissu conjonctif |
| Consciousness (observable entity) |
Wakefulness |
| Contact dermatitis due to other specified agents |
dermatite de contact |
| Continuous flow ventilation |
Controlled ventilation |
| Contraction of eye socket after enucleation |
Contraction of eye socket after enucleation |
| Controlled drug dependence |
Drug dependence |
| ventilation contrôlée (régime/thérapie) |
Continuous mandatory ventilation (regime/therapy) |
| Controlled mandatory ventilation with sigh |
Continuous mandatory ventilation with sigh |
| Contusion of eyelids AND/OR periocular area (disorder) |
Contusion of ocular adnexa |
| Contusion of face, except eye |
Contusion of face |
| Contusion of face, scalp and neck NOS |
Contusion of head and/or neck (disorder) |
| contusion du visage, du cuir chevelu et du cou, à l'exceptiondes yeux |
Contusion of head and/or neck (disorder) |
| Contusion of multiple sites, NEC |
Contusion of multiple sites |
| Intraocular solution |
solution pour injection (forme pharmaceutique) |
| Conventional release pressurized suspension for nebulizer (dose form) |
suspension pour inhalation par nébuliseur |
| Solution for intraocular injection |
solution pour injection (forme pharmaceutique) |
| Conversion disorder |
trouble dissociatif (trouble) |
| Convulsion (disorder) |
convulsion |
| Copper supplement (product) |
Product containing copper (medicinal product) |
| Cordylobia |
Cordylobia anthropophaga |
| Corkscrew esophagus (disorder) |
Diffuse spasm of esophagus |
| Corn oil - dietary |
Corn oil (substance) |
| Cornea guttata |
Corneal guttata (finding) |
| Corneal anesthesia |
Corneal anesthesia (finding) |
| Corneal endotheliolitis |
Corneal endotheliitis |
| Corneal epithelial and basement membrane dystrophy |
Epithelial basement membrane dystrophy (disorder) |
| Corneal fragility keratoglobus, blue sclerae AND joint hypermobility |
Brittle cornea syndrome (disorder) |
| Coronary artery dissection |
Dissection of coronary artery (disorder) |
| Coronary heart disease risk clinical management plan (qualifier value) |
Coronary heart disease risk clinical management plan |
| Coronary orifice atresia |
Congenital atresia of coronary ostium |
| Coronavirus |
Subfamily Orthocoronavirinae (organism) |
| Genus Coronavirus (organism) |
Subfamily Orthocoronavirinae (organism) |
| Corpus luteum of pregnancy |
Corpus luteum of pregnancy |
| Corpus uteri TNM finding (finding) |
American Joint Committee on Cancer allowable value |
| Correction of tricuspid atresia |
Repair of tricuspid atresia |
| Corrections Canada number |
Corrections Canada finger print system number (observable entity) |
| Corsodyl original mouthwash (product) |
Product manufactured as oromucosal dose form (product) |
| Cortex contusion with open intracranial wound and unspecified state of consciousness (disorder) |
Cortex contusion with open intracranial wound |
| Cortex contusion with open intracranial wound, with concussion, unspecified |
Contusion of cerebrum with open intracranial wound |
| Cortex contusion with open intracranial wound, with loss of consciousness of unspecified duration |
Contusion of cerebrum with open intracranial wound |
| Cortex contusion without open intracranial wound and with unspecified state of consciousness |
Cortex contusion without open intracranial wound |
| Cortex laceration with open intracranial wound and unspecified state of consciousness |
Cortex laceration with open intracranial wound (disorder) |
| Corticosteroid binding globulin |
Corticotropin binding globulin |
| Corynebacterium flaccumfaciens |
Curtobacterium flaccumfaciens |
| Corynebacterium flaccumfaciens subsp betae |
Curtobacterium flaccumfaciens |
| Corynebacterium flaccumfaciens subsp oortii |
Curtobacterium flaccumfaciens |
| Corynebacterium flaccumfaciens subsp poinsettiae |
Curtobacterium flaccumfaciens |
| Corynebacterium liquefaciens |
Brevibacterium liquefaciens |
| Corynebacterium nigricans (organism) |
Corynebacterium aurimucosum |
| Corynebacterium paurometabolum |
Tsukamurella paurometabola (organism) |
| Corynebacterium vitarumen |
Corynebacterium vitaeruminis (organism) |
| Count of active ingredient |
Count of active ingredient (attribute) |
| Count of base and modification pair |
Count of base and modification pair (attribute) |
| Count of base of active ingredient |
Count of base of active ingredient |
| Count of clinical drug type |
Count of clinical drug type (attribute) |
| Course |
évolution clinique (attribut) |
| Cowdria |
Genus Ehrlichia (organism) |
| Cowdria ruminantium |
Ehrlichia ruminantium (organism) |
| pelvis coxarthrolisthétique |
Arthritis of hip |
| Crab - dietary |
Crab (substance) |
| Cranial manipulation (procedure) |
Osteopathic cranial manipulative medicine (procedure) |
| Craniectomy, trephination, bone flap craniotomy for coagulation of choroid plexus |
Craniectomy |
| Craniectomy, trephination, bone flap craniotomy for total hemispherectomy |
cordotomie spinale |
| Craniofenestria (disorder) |
Craniolacunia |
| Craniosacral manipulation (procedure) |
Osteopathic cranial manipulative medicine (procedure) |
| Craniosynostosis with facial dysmorphism and brachydactyly syndrome (disorder) |
Fibroblast growth factor receptor 3-related craniosynostosis (disorder) |
| Crax mitu |
Mitu mitu (organism) |
| Crayfish - dietary |
Crayfish (substance) |
| Creation of arterioarterial bypass |
Arterial bypass graft |
| Creation of lesion of spinal cord by any modality (procedure) |
Spinal cord destructive procedure |
| Creation of oleothorax |
Procedure on thorax |
| Crimean fever (disorder) |
Crimean-Congo haemorrhagic fever |
| Cromoglycate and related antiallergenic allergy |
Allergy to cromoglicic acid (finding) |
| Cromolyn sodium 0.8mg/spray (product) |
Cromolyn sodium 800 microgram/actuation powder for inhalation |
| Cromolyn sodium 8.1g spray (product) |
Cromolyn sodium 800 microgram/actuation powder for inhalation |
| Cross-linked hyaluronic acid 24mg/mL injection gel |
Hyaluronic acid only product in parenteral dose form |
| Crown heel length |
Recumbent body height (observable entity) |
| Cruelty |
Cruel behavior |
| Crushing injury of multiple sites of shoulder AND/OR upper arm (disorder) |
Crushing injury of multiple sites of upper limb |
| Crushing injury of multiple sites, NEC (disorder) |
Crushing injury of multiple sites |
| Crustacean |
sous-embranchement : Crustacea |
| Cryptococcus albidus variant albidus (organism) |
Naganishia albida (organisme) |
FHIR